XML 38 R26.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Tables)
9 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of deferred tax assets and liabilities

The net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes are reflected in deferred income taxes. Significant components of the Company’s deferred tax assets consist of the following:

 

 

 

 

(In thousands)

 

 

 

December 31, 2022

 

 

March 31, 2022

 

Deferred Tax Assets:

 

 

 

 

 

 

Federal and State net operating loss carryforwards

 

$

2,365

 

 

$

507

 

Share-based compensation

 

 

14

 

 

 

79

 

Allowance for credit losses not currently deductible for tax purposes

 

 

2,998

 

 

 

900

 

Right of use liability

 

 

675

 

 

 

1,094

 

Other items

 

 

119

 

 

 

175

 

Gross deferred tax assets

 

 

6,171

 

 

 

2,755

 

Valuation allowance for deferred tax assets

 

 

(5,723

)

 

 

-

 

Net deferred tax assets

 

 

448

 

 

 

2,755

 

 

 

 

 

 

 

 

Deferred tax liabilities:

 

 

 

 

 

 

Right of use asset

 

 

290

 

 

 

1,061

 

Other items

 

 

158

 

 

 

309

 

Total deferred tax liabilities

 

 

448

 

 

 

1,370

 

Net deferred income taxes

 

$

-

 

 

$

1,385

 

Schedule of income tax expense reflects an effective U.S tax rate

Income tax expense reflects an effective U.S tax rate, which differs from the corporate tax rate for the following reasons:

 

 

 

(In thousands)

 

 

 

Three months ended

 

 

Nine months ended

 

 

 

December 31, 2022

 

 

December 31, 2022

 

Income tax expense at Federal statutory rate

 

$

(2,178

)

 

$

(3,530

)

State income taxes, net of Federal benefit

 

 

(398

)

 

 

(645

)

Increase (decrease) resulting from:

 

 

 

 

 

 

Change in Valuation Allowance

 

 

5,723

 

 

 

5,723

 

Other

 

 

(147

)

 

 

(133

)

Income tax expense

 

$

3,000

 

 

$

1,415

 

 

As of December 31, 2022 the Company has not generated sufficient positive evidence of future earnings to support a position that it will be able to realize its net deferred tax asset. The Company has significant negative evidence to overcome in the form of cumulative pre-tax losses from continuing operations as well as projected losses for the current year. Therefore, it will continue to maintain a full valuation allowance on its U.S. federal and state net deferred tax asset. The change in the valuation allowance offset

the income tax benefit related to the pre-tax loss for the quarter ended December 31, 2022. The Company does not have any material unrecognized tax benefits as of December 31, 2022.

The Company experienced a net change in valuation allowance of $5.7 million for the three and nine months ended December 31, 2022.